Other
Low-dose computed tomography (LDCT)
Low-dose computed tomography (LDCT) is an intervention with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(25%)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Terminated(1)
Other(1)
Detailed Status
Terminated1
unknown1
Not yet recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
terminated125%
unknown125%
not_yet_recruiting125%
active_not_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong
NCT07478757
active_not_recruitingnot_applicable
Low-Dose CT - Stage I Testicular Cancer
NCT03142802
terminated
PRogetto Salute Parma
NCT04282694
unknownphase_2
Image Discovering Early Lung Cancer Project
NCT01914458
Clinical Trials (4)
Showing 4 of 4 trials
NCT07478757Not Applicable
Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong
NCT03142802Not Applicable
Low-Dose CT - Stage I Testicular Cancer
NCT04282694
PRogetto Salute Parma
NCT01914458Phase 2
Image Discovering Early Lung Cancer Project
All 4 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 4